
Company profile · Onderzoeks- & kennisinstelling
MeiraGTx Netherlands B.V.
- Biotechnology
- Onderzoeks- & kennisinstelling
- Amsterdam
- Biotechnology · Amsterdam
- Employees
- 11–50
- Province
- Noord-Holland
- Country
- Netherlands
About MeiraGTx Netherlands B.V.
MeiraGTx Netherlands B.V. is an Amsterdam based biopharmaceutical company developing local gene therapy for different indications. The company specializes in the development of viral gene therapy vectors, in particular adeno-associated virus (AAV) based therapeutics. Our goal is to develop potentially curative treatments for patients living with serious diseases. Several product candidates are in the discovery and development phase. Meira GTx Netherlands B.V. is a wholly-owned subsidiary of MeiraGTx Holdings plc. With sites in New York, London, Shannon and Amsterdam, our global footprint provides us the opportunity to partner with leading institutions around the world, allowing us to deepen our understanding of diseases and their progression.
Address
Headquarters
Paalbergweg 21105AG AmsterdamNoord-Holland, Netherlands
Team by function
Based on 3 public job profiles as of 4 September 2026.
- Healthcare / Medical1
- HR / People / Recruiting1
- Manufacturing / Production1
Similar companies
Companies with a similar profile, Noord-Holland first.
CureVac Netherlands
Pharmaceuticals · Amsterdam
11–50 employeesView profile

VectorY
Biotechnology · Amsterdam
51–200 employeesView profile

SanaGen B.V.
Biotechnology · Amsterdam
2–10 employeesView profile

Neogene Therapeutics
Biotechnology · Amsterdam
51–200 employeesView profile

BGV BioGeneration Ventures
Venture Capital & Private Equity · Naarden
2–10 employeesView profile
Gen-X B.V.
Biotechnology · Amsterdam
View profile